ondansetron
Generic: ondansetron
Labeler: asclemed usa, inc.Drug Facts
Product Profile
Brand Name
ondansetron
Generic Name
ondansetron
Labeler
asclemed usa, inc.
Dosage Form
TABLET, ORALLY DISINTEGRATING
Routes
Active Ingredients
ondansetron 8 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
76420-251
Product ID
76420-251_2eaaa08a-db13-8991-e063-6294a90ac450
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090469
Listing Expiration
2026-12-31
Marketing Start
2010-04-12
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76420251
Hyphenated Format
76420-251
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ondansetron (source: ndc)
Generic Name
ondansetron (source: ndc)
Application Number
ANDA090469 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 8 mg/1
Packaging
- 4 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-251-04)
- 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-251-06)
- 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-251-10)
- 20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-251-20)
- 3 BLISTER PACK in 1 CARTON (76420-251-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Packages (5)
76420-251-04
4 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-251-04)
76420-251-06
6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-251-06)
76420-251-10
10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-251-10)
76420-251-20
20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-251-20)
76420-251-30
3 BLISTER PACK in 1 CARTON (76420-251-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2eaaa08a-db13-8991-e063-6294a90ac450", "openfda": {"nui": ["N0000175817", "N0000175818"], "unii": ["4AF302ESOS"], "rxcui": ["104894", "312087"], "spl_set_id": ["e436e361-da0f-7d6d-e053-2995a90a10e4"], "pharm_class_epc": ["Serotonin-3 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Serotonin 3 Receptor Antagonists [MoA]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "4 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-251-04)", "package_ndc": "76420-251-04", "marketing_start_date": "20220720"}, {"sample": false, "description": "6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-251-06)", "package_ndc": "76420-251-06", "marketing_start_date": "20220720"}, {"sample": false, "description": "10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-251-10)", "package_ndc": "76420-251-10", "marketing_start_date": "20220720"}, {"sample": false, "description": "20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76420-251-20)", "package_ndc": "76420-251-20", "marketing_start_date": "20220720"}, {"sample": false, "description": "3 BLISTER PACK in 1 CARTON (76420-251-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK", "package_ndc": "76420-251-30", "marketing_start_date": "20220720"}], "brand_name": "Ondansetron", "product_id": "76420-251_2eaaa08a-db13-8991-e063-6294a90ac450", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Serotonin 3 Receptor Antagonists [MoA]", "Serotonin-3 Receptor Antagonist [EPC]"], "product_ndc": "76420-251", "generic_name": "Ondansetron", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ondansetron", "active_ingredients": [{"name": "ONDANSETRON", "strength": "8 mg/1"}], "application_number": "ANDA090469", "marketing_category": "ANDA", "marketing_start_date": "20100412", "listing_expiration_date": "20261231"}